You just read:

Helsinn and Chugai Pharma Marketing Enter into Agreement for Rights of Anamorelin, Currently in Development for Treatment of Anorexia-Cachexia Syndrome Related to Non-small Cell Lung Cancer in top EU Markets

News provided by

Helsinn Healthcare SA

Nov 11, 2013, 10:00 ET